Navigation Links
TPI Reports Third Quarter Fiscal Year 2013 Financial Results
Date:5/14/2013

CHENGDU, China, May 14, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for third quarter of the fiscal year 2013.

Third Quarter Fiscal Year 2013 Ended March 31, 2013 Financial Highlights:

  • Revenue was $15.5 million compared with $14.4 million in 3Q12 an increase of 8.1% year over year,
  • Operating income was $1.8 million, compared with $1.3 million in 3Q12, an increase of 38.8% year over year,
  • Net Income was $1.3 million compared with $0.9 million in 3Q12, an increase of 40.9% year over year,
  • Earnings per share of $0.04 per basic share, $0.04 per diluted share, compared with $0.03 per basic share, or $0.03 per diluted share in 3Q12, 
  • Cash and cash equivalents totaled $26.4 million on March 31, 2013; Operating cash flow for the nine months ended March 31, 2013 was $0.8 million, compared with operating cash flow of $4.6 million for the nine months ended March 31, 2012.
  • Comparison of results for the quarters ended March 31, 2013 and 2012:QuartersEnded March 31,20132012 

    (In millions)Sales$

    15.5$

    14.4Cost of sales$

    9.7$

    9.5Gross profit$

    5.9$

    4.8Total operating expenses$

    4.1$

    3.5Operating income$

    1.8$

    1.3Provision for income taxes$

    0.5$

    0.4Net income$

    1.3$

    0.9 

    Sales for the quarter ended March 31, 2013 was $15.5 million, an increase of 8.1% as compared to $14.4 million for the quarter ended March 31, 2012. Due to the holiday season in the quarters ended March 31, including Chinese New Year in February and the following Yuanxiao Festival,
    '/>"/>

    SOURCE Tianyin Pharmaceutical Co., Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. KaloBios Reports First Quarter 2013 Financial Results
    2. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
    3. Alexza Reports 2013 First Quarter Financial Results
    4. Encision Reports Fourth Quarter and Fiscal Year 2013 Results
    5. Patient Safety Technologies Reports First Quarter 2013 Results
    6. PDI Reports 2013 First Quarter Financial Results
    7. SPO Reports Results for First Quarter 2013
    8. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
    9. Allied Healthcare Products Reports Loss On Depressed Sales
    10. Neuland Labs Reports Financial Results For Fiscal Year 2013
    11. Omeros Corporation Reports First Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... CHESTERBROOK, Pa. and STOCKHOLM ... AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today ... Use (CHMP) of the European Medicines Agency (EMA) has ... (collagenase clostridium histolyticum) for the treatment of adult men ... deformity of at least 30 degrees at the start ...
    (Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
    (Date:12/22/2014)... , Dec. 22, 2014  Pfenex Inc. (NYSE ... recombinant anthrax vaccine, has been filed and is now ... provided by the Department of Health and Human Services ... (BARDA). "We are extremely pleased to have ... Px563L.  This represents a significant milestone in our company,s ...
    Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3
    ... Ikaria Holdings, Inc. today announced that it has been ... by the New Jersey Business & Industry Association (NJBIA), ... Ikaria earned the award based on criteria including ... creation of new jobs. , "We are delighted that ...
    ... 21 PharmaNet Development Group, Inc., a leading provider ... and medical device companies, today announced its participation at ... place at the World Trade Center in Rotterdam, The ... the conference, top management will discuss some of the ...
    Cached Medicine Technology:Ikaria Receives Award for Excellence by New Jersey Business & Industry Association 2PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam 2
    (Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
    (Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
    (Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
    (Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
    (Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... Ducks Publishing announces the winning of the Mom,s Choice Award for ... The award-winning book, a remarkably frank account of prostate cancer survival, ... , ... South Bend, IN (PRWEB) March 19, 2009 ...
    ... March 19 The "2009 European Mammography ... to FUJIFILM Corporation in recognition of the ... mammography systems. The company,s superior quality control, ... manufacturing are also commended.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
    ... designed to extend audit reach for customers that need ... SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: ... new Vendor Audit Services aimed at customers ... raw materials and key intermediates destined for their manufacturing ...
    ... For women with recurrent breast cancer, the treatment the ... original breast cancer. A group from Toronto has recently completed ... with a biopsy of suspected tumors that recurred elsewhere in ... 20% of the women having a significant change in their ...
    ... Injury Awareness MonthWHEATON, Ill., March 18 Sports and recreation ... in the U.S. each year according to the Centers for ... traumatic brain injury (TBI) caused by a blow or jolt ... It is important to note that even if you do ...
    ... Keystone Symposia on Molecular and Cellular Biology will ... in 1984 when it convenes its scientific conferences on ... From Infection to Immune Control " at Keystone Resort ... from around the world will attend.These joint conferences will ...
    Cached Medicine News:Health News:Cancer Book Honored With Prestigious Mom's Choice Award 2Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 2Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 3Health News:Frost & Sullivan Recognises FUJIFILM Corporation's Outstanding Product Quality Leadership 4Health News:SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services 2Health News:SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services 3Health News:SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services 4Health News:Research shows biopsy of recurrent breast cancer can alter treatment 2Health News:Sports Concussions: Common and Preventable 2Health News:Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting 2Health News:Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting 3
    ... has the right product for any patient ... intubated patients to patients with tracheotomies. These ... and critical care applications., ,The Unti-Mist ... patients and staff members. This entire product ...
    Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
    Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
    Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
    Medicine Products: